CURX
Curanex Pharmaceuticals Inc
Key Financials
Net Income
$-4225106
↓ 1068.8%
Operating Income
$-4239076
↓ 1061.2%
EPS (Diluted)
$-0.17
↓ 466.7%
Cash & Equivalents
$5.0M
N/A
Total Liabilities
$361040.00
↑ 2377.1%
Total Assets
$11.6M
↑ 2135.8%
Shareholders' Equity
$11.2M
↑ 2128.8%
Operating Cash Flow
$-10484452.00
↓ 1787.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 4/2/2026 | View on SEC |
| 10-K | 3/30/2026 | View on SEC |
| 8-K | 3/6/2026 | View on SEC |
| 8-K | 1/5/2026 | View on SEC |
| 10-Q | 11/17/2025 | View on SEC |
| NT 10-Q | 11/17/2025 | View on SEC |
| 8-K | 11/6/2025 | View on SEC |
| 8-K | 9/29/2025 | View on SEC |
| 8-K | 9/12/2025 | View on SEC |
| 10-Q | 9/9/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CURX |
| Company Name | Curanex Pharmaceuticals Inc |
| CIK | 2025942 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 718-673-6078 |